Atlas Trials

Patients With Patent Foramen Ovale and Endocardial Device Leads on Apixaban for Prevention of Paradoxical Emboli

Clinical trial NCT02378623 · WITHDRAWN

Trial details

NCT number
NCT02378623
Sponsor
Mayo Clinic
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Patent Foramen OvaleCardiac Implantable Electronic Device
Start date
2015-05-01
Primary completion
2020-01-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.